Friday, November 22, 2024
HomeTagsSelinexor

Selinexor

Karyopharm and Menarini Group Announce Orphan Medicinal Product Designation from the European Commission for Selinexor for the Treatment of Myelofibrosis

Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company pioneering novel cancer therapies, and the Menarini Group ("Menarini"), a privately-held, leading international pharmaceutical company, announced that...

Antengene Announces Clinical Trial Collaboration with BeiGene to Evaluate Selinexor

Antengene Corporation Limited, a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class therapeutics in hematology and oncology,...

Antengene Announces Commercial Availability of XPOVIO (Selinexor)

Antengene Corporation Limited, a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class therapeutics in hematology and oncology,...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics